These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7692676)

  • 1. Use of aprotinin to reduce intraoperative bleeding.
    Feeley TW; Rinsky LA
    West J Med; 1993 Aug; 159(2):189-92. PubMed ID: 7692676
    [No Abstract]   [Full Text] [Related]  

  • 2. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprotinin reduces blood loss during spinal surgery in children.
    Cole JW; Murray DJ; Snider RJ; Bassett GS; Bridwell KH; Lenke LG
    Spine (Phila Pa 1976); 2003 Nov; 28(21):2482-5. PubMed ID: 14595168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin may decrease blood loss in complex adult spinal deformity surgery, but it may also increase the risk of acute renal failure.
    Okubadejo GO; Bridwell KH; Lenke LG; Buchowski JM; Fang DD; Baldus CR; Nielsen CH; Lee CC
    Spine (Phila Pa 1976); 2007 Sep; 32(20):2265-71. PubMed ID: 17873821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty.
    Langdown AJ; Field J; Grote J; Himayat H
    J Arthroplasty; 2000 Dec; 15(8):1009-12. PubMed ID: 11112196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
    Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
    Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprotinin therapy in heart and heart-lung transplantation.
    Royston D
    J Heart Lung Transplant; 1993; 12(1 Pt 1):S19-25. PubMed ID: 7680233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized placebo-controlled trial of aprotinin for elective aortic reconstruction.
    Ranaboldo CJ; Thompson JF; Davies JN; Shutt AM; Francis JN; Roath OS; Webster JH; Chant AD
    Br J Surg; 1997 Aug; 84(8):1110-3. PubMed ID: 9278654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid.
    Colomina MJ; Bagó J; Vidal X; Mora L; Pellisé F
    Orthopedics; 2009 Feb; 32(2):91. PubMed ID: 19301800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does aprotinin lessen intraoperative blood loss?].
    Wollinsky KH; Mehrkens HH; Freytag T; Geiger P; Weindler M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Jun; 26(4):208-10. PubMed ID: 1716471
    [No Abstract]   [Full Text] [Related]  

  • 11. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis.
    Gill JB; Rosenstein A
    J Arthroplasty; 2006 Sep; 21(6):869-73. PubMed ID: 16950041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aprotinin reduces intraoperative bleeding during spinal arthrodesis interventions].
    Llau JV; Hoyas L; Higueras J; Ezpeleta J; García-Polit J
    Rev Esp Anestesiol Reanim; 1996 Mar; 43(3):118. PubMed ID: 8848642
    [No Abstract]   [Full Text] [Related]  

  • 14. ICVTS on-line discussion A Plateletpheresis or aprotinin, which is the key element?
    Kan CD
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):622; discussion 622. PubMed ID: 17884856
    [No Abstract]   [Full Text] [Related]  

  • 15. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis.
    Shapiro F; Zurakowski D; Sethna NF
    Spine (Phila Pa 1976); 2007 Sep; 32(20):2278-83. PubMed ID: 17873823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
    Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
    Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aprotinin -- an allogeneic transfusion sparing drug].
    Haas S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):38-40. PubMed ID: 12522728
    [No Abstract]   [Full Text] [Related]  

  • 18. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical evaluation of blood-saving measures for high-risk patients.
    Hartmann T; Winkler M; Preis C; Germann P; Donner A; Müller C
    Acta Anaesthesiol Scand Suppl; 1997; 111():207-9. PubMed ID: 9421015
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.